Thomas D'Orazio

Thomas D'Orazio

Amministratore Delegato presso Phoenix LLC

Health Technology
Consumer Services
Commercial Services

Profilo

Thomas D'Orazio was the founder of Superna Life Sciences, Inc. founded in 2009, where he held the title of Chief Executive Officer.
Currently, he is the Chief Executive Officer at Phoenix LLC and Chairman at Vrrk Medical Innovations, Inc. In the past, he held positions such as President, Chief Executive Officer & Director at ImmunoPrecise Antibodies Ltd., Vice President-Strategic Marketing at Sonus Pharmaceuticals, Inc., Vice President-Business Development & Strategy at Sophiris Bio, Inc., Principal at QLT, Inc. and Merck Canada, Inc., and Chief Operating Officer at Tryp Therapeutics, Inc. Mr. D'Orazio holds an MBA degree from Vanderbilt University and an undergraduate degree from Loyola University of Chicago.

Posizioni attive di Thomas D'Orazio

SocietàPosizioneInizio
Presidente -
Amministratore Delegato 16/08/2022
Tutte le posizioni attive di Thomas D'Orazio

Precedenti posizioni note di Thomas D'Orazio

SocietàPosizioneFine
TRYPTAMINE THERAPEUTICS LIMITED Direttore operativo 23/06/2022
IMMUNOPRECISE ANTIBODIES LTD. Amministratore Delegato 20/11/2017
Corporate Officer/Principal -
Corporate Officer/Principal -
Amministratore Delegato -
Vedi nel dettaglio l'esperienza di Thomas D'Orazio

Formazione di Thomas D'Orazio

Vanderbilt University Masters Business Admin
Loyola University of Chicago Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Thomas D'Orazio

Relazioni

19

Relazioni di 1° grado

11

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa1
IMMUNOPRECISE ANTIBODIES LTD.

Health Technology

Aziende private8

Commercial Services

Health Technology

Health Technology

Retail Trade

Distribution Services

Health Technology

Producer Manufacturing

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Thomas D'Orazio